Self-reported challenges obtaining ongoing prescription opioids among Australians with chronic non-cancer pain.

[1]  M. Choinière,et al.  Doctor shopping among chronic noncancer pain patients treated with opioids in the province of Quebec (Canada): incidence, risk factors, and association with the occurrence of opioid overdoses , 2021, Pain reports.

[2]  A. Jerant,et al.  Association of Dose Tapering With Overdose or Mental Health Crisis Among Patients Prescribed Long-term Opioids. , 2021, JAMA.

[3]  B. Sproule,et al.  Impact of changes in opioid funding and clinical policies on rapid tapering of opioids in Ontario, Canada , 2021, Pain.

[4]  K. Fairfield,et al.  Prescription opioid policies and associations with opioid overdose and related adverse effects. , 2021, The International journal on drug policy.

[5]  T. Luckett,et al.  General practitioner attitudes towards systems-level opioid prescribing interventions: A pooled secondary qualitative analysis. , 2021, Australian journal of general practice.

[6]  C. Hayes,et al.  Opioid cessation is associated with reduced pain and improved function in people attending specialist chronic pain services , 2021, The Medical journal of Australia.

[7]  F. Blyth,et al.  Pharmaceutical Opioid Use Patterns and Indicators of Extramedical Use and Harm in Adults With Chronic Noncancer Pain, 2012-2018 , 2021, JAMA network open.

[8]  N. Stocks,et al.  Trends in long-term opioid prescriptions for musculoskeletal conditions in Australian general practice: a national longitudinal study using MedicineInsight, 2012–2018 , 2021, BMJ Open.

[9]  A. Bazzi,et al.  "I felt like I had a scarlet letter": Recurring experiences of structural stigma surrounding opioid tapers among patients with chronic, non-cancer pain. , 2021, Drug and alcohol dependence.

[10]  Shane R Mueller,et al.  Restrictive opioid prescribing policies and evolving risk environments: A qualitative study of the perspectives of patients who experienced an accidental opioid overdose. , 2021, The International journal on drug policy.

[11]  M. Choinière,et al.  “They think you’re trying to get the drug”: Qualitative investigation of chronic pain patients’ health care experiences during the opioid overdose epidemic in Canada , 2021, Canadian journal of pain = Revue canadienne de la douleur.

[12]  Joseph W. Frank,et al.  Association Between Opioid Dose Reduction Against Patients’ Wishes and Change in Pain Severity , 2020, Journal of General Internal Medicine.

[13]  M. Dobbin,et al.  Real-time prescription monitoring: helping people at risk of harm , 2020, Australian prescriber.

[14]  Daniel M. Hartung,et al.  Patient Outcomes Following Opioid Dose Reduction Among Patients with Chronic Opioid Therapy , 2020 .

[15]  Travis N. Rieder.  Is Nonconsensual Tapering of High-Dose Opioid Therapy Justifiable? , 2020, AMA journal of ethics.

[16]  R. Buchbinder,et al.  What proportion of patients with chronic noncancer pain are prescribed an opioid medicine? Systematic review and meta‐regression of observational studies , 2020, Journal of internal medicine.

[17]  R. Bruno,et al.  Correlates of indicators of potential extra-medical opioid use in people prescribed opioids for chronic non-cancer pain. , 2019, Drug and alcohol review.

[18]  D. Mazza,et al.  Qualitative insights into the opioid prescribing practices of Australian GP. , 2019, Family practice.

[19]  L. Sharpe,et al.  Reducing the use of opioids by patients with chronic pain: an effectiveness study with long-term follow-up. , 2019, Pain.

[20]  C. Maier,et al.  Efficacy and harms of long‐term opioid therapy in chronic non‐cancer pain: Systematic review and meta‐analysis of open‐label extension trials with a study duration ≥26 weeks , 2019, European journal of pain.

[21]  K. Leslie,et al.  Post-surgical opioid stewardship programs across Australia and New Zealand: Current situation and future directions , 2019, Anaesthesia and intensive care.

[22]  JoAnna M Scott,et al.  Mortality After Discontinuation of Primary Care–Based Chronic Opioid Therapy for Pain: a Retrospective Cohort Study , 2019, Journal of General Internal Medicine.

[23]  M. Heo,et al.  Opioid Taper Is Associated with Subsequent Termination of Care: a Retrospective Cohort Study , 2019, Journal of General Internal Medicine.

[24]  B. Larance,et al.  Regulatory and other responses to the pharmaceutical opioid problem , 2019, The Medical journal of Australia.

[25]  P. Poulin,et al.  Understanding the High Frequency Use of the Emergency Department for Patients With Chronic Pain: A Mixed-Methods Study. , 2019, Journal for healthcare quality : official publication of the National Association for Healthcare Quality.

[26]  R. Chou,et al.  No Shortcuts to Safer Opioid Prescribing. , 2019, The New England journal of medicine.

[27]  T. Gomes,et al.  "Like being put on an ice floe and shoved away": A qualitative study of the impacts of opioid-related policy changes on people who take opioids. , 2019, The International journal on drug policy.

[28]  Michael B. First,et al.  Chronic pain as a symptom or a disease: the IASP Classification of Chronic Pain for the International Classification of Diseases (ICD-11) , 2019, Pain.

[29]  N. Gisev,et al.  Prevalence and incidence of prescription opioid analgesic use in Australia , 2018, British journal of clinical pharmacology.

[30]  Joseph W. Frank,et al.  “Those Conversations in My Experience Don’t Go Well”: A Qualitative Study of Primary Care Provider Experiences Tapering Long-term Opioid Medications , 2018, Pain medicine.

[31]  N. Gisev,et al.  Current Opioid Access, Use, and Problems in Australasian Jurisdictions , 2018, Current Addiction Reports.

[32]  S. Dobscha,et al.  Changes in pain intensity after discontinuation of long-term opioid therapy for chronic noncancer pain , 2018, Pain.

[33]  Tara Gomes,et al.  The Burden of Opioid-Related Mortality in the United States , 2018, JAMA network open.

[34]  C. Shields,et al.  "I'm Not Gonna Pull the Rug out From Under You": Patient-Provider Communication About Opioid Tapering. , 2017, The journal of pain : official journal of the American Pain Society.

[35]  D. Revere,et al.  Exploring perceptions and experiences of patients who have chronic pain as state prescription opioid policies change: a qualitative study in Indiana , 2017, BMJ Open.

[36]  W. Hall,et al.  Trends in heroin and pharmaceutical opioid overdose deaths in Australia. , 2017, Drug and alcohol dependence.

[37]  C. Miaskowski,et al.  The Risks of Opioid Treatment: Perspectives of Primary Care Practitioners and Patients from Safety-Net Clinics , 2017, Substance abuse.

[38]  Ariel M. Aloe,et al.  Extracting the Variance Inflation Factor and Other Multicollinearity Diagnostics from Typical Regression Results , 2017 .

[39]  Feng Chang,et al.  Perceptions of Community-Dwelling Patients and Their Physicians on OxyContin® Discontinuation and the Impact on Chronic Pain Management , 2017, Pain research & management.

[40]  A. Eschalier,et al.  Incidence of tramadol shopping behavior in a retrospective cohort of chronic non‐cancer pain patients in France , 2016, Pharmacoepidemiology and drug safety.

[41]  F. Blyth,et al.  Defining problematic pharmaceutical opioid use among people prescribed opioids for chronic noncancer pain: do different measures identify the same patients? , 2016, Pain.

[42]  N. Gisev,et al.  A synthesis of oral morphine equivalents (OME) for opioid utilisation studies , 2016, Pharmacoepidemiology and drug safety.

[43]  B. Lloyd,et al.  Prescription drug monitoring in Australia: capacity and coverage issues , 2016, The Medical journal of Australia.

[44]  R. Mattick,et al.  Development of a brief tool for monitoring aberrant behaviours among patients receiving long-term opioid therapy: The Opioid-Related Behaviours In Treatment (ORBIT) scale. , 2016, Drug and alcohol dependence.

[45]  R. Chou,et al.  CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016. , 2016, JAMA.

[46]  R. Chou,et al.  The Effectiveness and Risks of Long-Term Opioid Therapy for Chronic Pain: A Systematic Review for a National Institutes of Health Pathways to Prevention Workshop , 2015, Annals of Internal Medicine.

[47]  A. Unruh,et al.  Exploring the lived experience of adults using prescription opioids to manage chronic noncancer pain , 2015, Pain research & management.

[48]  J. Borkan,et al.  Doctors and patients in pain: Conflict and collaboration in opioid prescription in primary care , 2014, PAIN®.

[49]  R. Bruno,et al.  Diversion of prescribed opioids by people living with chronic pain: results from an Australian community sample. , 2014, Drug and alcohol review.

[50]  W. Hall,et al.  Cohort protocol paper: The Pain and Opioids In Treatment (POINT) study , 2014, BMC Pharmacology and Toxicology.

[51]  A. Winstock,et al.  Definitions related to the use of pharmaceutical opioids: extramedical use, diversion, non-adherence and aberrant medication-related behaviours. , 2011, Drug and alcohol review.

[52]  T. Gomes,et al.  Opioid dose and drug-related mortality in patients with nonmalignant pain. , 2011, Archives of internal medicine.

[53]  S. Tregear,et al.  Long-term opioid management for chronic noncancer pain. , 2010, The Cochrane database of systematic reviews.

[54]  G. Pasternak,et al.  Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. , 2009, The journal of pain : official journal of the American Pain Society.

[55]  L. Webster,et al.  Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool. , 2005, Pain medicine.

[56]  H. Heit,et al.  Universal precautions in pain medicine: a rational approach to the treatment of chronic pain. , 2005, Pain medicine.

[57]  J. Wilson‐Barnett,et al.  A survey of chronic noncancer pain patients prescribed opioid analgesics. , 2003, Pain medicine.

[58]  P M Bentler,et al.  A two-stage estimation of structural equation models with continuous and polytomous variables. , 1995, The British journal of mathematical and statistical psychology.